WAY-647802

CAS No. 852225-20-8

WAY-647802( —— )

Catalog No. M28995 CAS No. 852225-20-8

WAY-647802 is a CDK inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 31 In Stock
5MG 50 In Stock
10MG 74 In Stock
25MG 119 In Stock
50MG 179 In Stock
100MG 263 In Stock
200MG 375 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WAY-647802
  • Note
    Research use only, not for human use.
  • Brief Description
    WAY-647802 is a CDK inhibitor.
  • Description
    WAY-647802 is a CDK inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    Ezh2 (wild-type)| EZH2 (Y641F)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    852225-20-8
  • Formula Weight
    250.258
  • Molecular Formula
    C11H14N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(=O)N1CCN(CC1)c1ccc(nc1)[N+]([O-])=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhou B, et al. Discovery of IHMT-EZH2-115 as a Potent and Selective Enhancer of Zeste Homolog 2 (EZH2) Inhibitor for the Treatment of B-Cell Lymphomas. J Med Chem. 2021 Oct 28;64(20):15170-15188.
molnova catalog
related products
  • PNU-112455A

    PNU-112455A is an ATP-competitive CDK2/5 inhibitor with Ki of 2 uM and 2 uM for cdk2·GST-cyclin E and cdk5·GST-p25 respectively.

  • Atuveciclib Racemate

    Atuveciclib (BAY-1143572) inhibits the proliferation of 7 MLL-rearrangements positive and negative AML cell lines with a median IC50 of 385 nM (range 230-1100 nM) and induces apoptosis.

  • iCDK9

    iCDK9 (i-CDK9) is a potent, highly selective CDK9 inhibitor (IC50<0.4 nM, CDK9-CycT1 kinase), exhibits >600-fold selectivity toward CDK1-CycB, CDK2-CycA, CDK4-CycD1, CDK7-CycH-MAT1 and CDK8-CycC.